Continuous glucose monitoring (CGM) has moved from a niche tool for Type 1 diabetes to a mainstream part of connected diabetes care. Grand View Research values the global continuous glucose monitoring devices market at USD 13.4 billion in 2025. It projects growth to USD 15.5 billion in 2026 and USD 41.4 billion by 2033, a 15.1% CAGR. Here is who is winning, who is challenging them, and which...
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)